1.
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.
2.
3.
4.
5.
6.
7.
Exposure to Ambient Air Pollution and the Risk of Inflammatory Bowel Disease: A European Nested Case-Control Study.